2017-2022 Renal Biomarkers Report on Global and United States Market, Status and Forecast, by Players, Types and Applications


Report ID : RNR-77443 Category : Biotechnology Published Date : Apr 2017
Publisher : QYResearch Pages : 137 Format : PDF
This report studies the Renal Biomarkers market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Renal Biomarkers market by product type and applications/end industries.

The global Renal Biomarkers market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Renal Biomarkers. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX. 

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Renal Biomarkers in these regions, from 2012 to 2022 (forecast), covering
United States
North America
Europe
Asia-Pacific 
South America
Middle East and Africa

The major players in global and United States Renal Biomarkers market, including Astute Medical, BioMrieux, Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Alere Inc., Randox Laboratories Ltd.,, 

The On the basis of product, the Renal Biomarkers market is primarily split into 
Creatinine
Blood urea nitrogen (BUN) 
Cystatin C
Neutrophil gelatinase-associated lipocalin (NGAL)

On the basis on the end users/applications, this report covers 
Diagnosis and disease progression monitoring
Research
Table of Contents

2017-2022 Renal Biomarkers Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
2.1.1 Secondary Sources
2.1.2 Primary Sources
1.3 Disclaimer
2 Renal Biomarkers Market Overview
2.1 Renal Biomarkers Product Overview
2.2 Renal Biomarkers Market Segment by Type
2.2.1 Creatinine
2.2.2 Blood urea nitrogen (BUN) 
2.2.3 Cystatin C
2.2.4 Neutrophil gelatinase-associated lipocalin (NGAL)
2.3 Global Renal Biomarkers Product Segment by Type
2.3.1 Global Renal Biomarkers Sales (K Units) and Growth (%) by Types (2012, 2016 and 2022)
2.3.2 Global Renal Biomarkers Sales (K Units) and Market Share (%) by Types (2012-2017)
2.3.3 Global Renal Biomarkers Revenue (Million USD) and Market Share (%) by Types (2012-2017)
2.3.4 Global Renal Biomarkers Price (USD/Unit) by Type (2012-2017)
2.4 United States Renal Biomarkers Product Segment by Type
2.4.1 United States Renal Biomarkers Sales (K Units) and Growth by Types (2012, 2016 and 2022)
2.4.2 United States Renal Biomarkers Sales (K Units) and Market Share by Types (2012-2017)
2.4.3 United States Renal Biomarkers Revenue (Million USD) and Market Share by Types (2012-2017)
2.4.4 United States Renal Biomarkers Price (USD/Unit) by Type (2012-2017)
3 Renal Biomarkers Application/End Users
3.1 Renal Biomarkers Segment by Application/End Users
3.1.1 Diagnosis and disease progression monitoring
3.1.2 Research
3.2 Global Renal Biomarkers Product Segment by Application
3.2.1 Global Renal Biomarkers Sales (K Units) and CGAR (%) by Applications (2012, 2016 and 2022)
3.2.2 Global Renal Biomarkers Sales (K Units) and Market Share (%) by Applications (2012-2017)
3.3 United States Renal Biomarkers Product Segment by Application
3.3.1 United States Renal Biomarkers Sales (K Units) and CGAR (%) by Applications (2012, 2016 and 2022)
3.3.2 United States Renal Biomarkers Sales (K Units) and Market Share (%) by Applications (2012-2017)
4 Renal Biomarkers Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Renal Biomarkers Market Size and CAGR by Regions (2012, 2016 and 2022)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Renal Biomarkers Sales and Revenue by Regions
4.2.1 Global Renal Biomarkers Sales (K Units) and Market Share (%) by Regions (2012-2017)
4.2.2 Global Renal Biomarkers Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
4.2.3 Global Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.4 North America Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.5 Europe Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.6 Asia-Pacific Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.7 South America Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
4.2.8 Middle East and Africa Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4.2.9 United States Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
5 Global Renal Biomarkers Market Competition by Players/Manufacturers
5.1 Global Renal Biomarkers Sales (K Units) and Market Share by Players (2012-2017)
5.2 Global Renal Biomarkers Revenue (Million USD) and Share by Players (2012-2017)
5.3 Global Renal Biomarkers Average Price (USD/Unit) by Players (2012-2017)
5.4 Players Renal Biomarkers Manufacturing Base Distribution, Sales Area, Product Types
5.5 Renal Biomarkers Market Competitive Situation and Trends
5.5.1 Renal Biomarkers Market Concentration Rate
5.5.2 Global Renal Biomarkers Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Renal Biomarkers Market Competition by Players/Manufacturers
6.1 United States Renal Biomarkers Sales (K Units) and Market Share by Players (2012-2017)
6.2 United States Renal Biomarkers Revenue (Million USD) and Share by Players (2012-2017)
6.3 United States Renal Biomarkers Average Price (USD/Unit) by Players (2012-2017)
6.4 United States Renal Biomarkers Market Share (%) of Top 3 and Top 5 Players
7 Renal Biomarkers Players/Manufacturers Profiles and Sales Data
7.1 Astute Medical
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Renal Biomarkers Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Astute Medical Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.1.4 Main Business/Business Overview
7.2 BioMrieux
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Renal Biomarkers Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 BioMrieux Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Abbott Diagnostics
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Renal Biomarkers Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Abbott Diagnostics Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.3.4 Main Business/Business Overview
7.4 F. Hoffmann-La Roche AG
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Renal Biomarkers Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 F. Hoffmann-La Roche AG Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Beckman Coulter Inc.
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Renal Biomarkers Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Beckman Coulter Inc. Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Siemens Healthcare Diagnostics Inc.
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Renal Biomarkers Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Siemens Healthcare Diagnostics Inc. Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Thermo Fisher Scientific Inc.
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Renal Biomarkers Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Thermo Fisher Scientific Inc. Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Alere Inc.
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Renal Biomarkers Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Alere Inc. Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Randox Laboratories Ltd.,
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Renal Biomarkers Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Randox Laboratories Ltd., Renal Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.9.4 Main Business/Business Overview
8 Renal Biomarkers Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Renal Biomarkers Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Renal Biomarkers Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Renal Biomarkers Market Forecast
10.1 Global Renal Biomarkers Sales, Revenue Forecast (2017-2022)
10.1.1 Global Renal Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
10.1.2 Global Renal Biomarkers Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
10.2 United States Renal Biomarkers Market Forecast
10.1.1 United States Renal Biomarkers Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
10.2.2 United States Renal Biomarkers Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
10.3 Global Renal Biomarkers Forecast by Regions
10.3.1 North America Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.2 Europe Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.3 Asia-Pacific Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.4 South America Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.3.5 Middle East and Africa Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
10.4 Renal Biomarkers Forecast by Type
10.4.1 Global Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast by Type (2017-2022)
10.4.2 United States Renal Biomarkers Sales (K Units) and Revenue (Million USD) Forecast by Type (2017-2022)
10.5 Renal Biomarkers Forecast by Application
10.5.1 Global Renal Biomarkers Sales (K Units) Forecast by Application (2017-2022)
10.5.2 United States Renal Biomarkers Sales (K Units) Forecast by Application (2017-2022)
11 Research Findings and Conclusion